-
Moderna will ask the Food and Drug Administration to authorize its vaccine for kids from age 12 to 17 in early June, the company's CEO says.
-
Researchers hope to learn about the effectiveness of the vaccine for kids ages 6 months to less than 12 years old. Moderna plans to enroll roughly 6,750 children in eight U.S. states and Canada.
-
Pfizer and Moderna each agreed to supply 100 million doses of COVID-19 vaccine to the U.S. by the end of March. With just under three weeks left, both companies have their work cut out for them.
-
The two companies producing COVID-19 vaccines for use in the United States will have to raise production to meet contractual goals of 100 million doses each by the end of March.
-
The two companies making COVID-19 vaccines each promised to deliver 100 million doses to the federal government by the end of March. So far, they appear to be running behind.
-
This post will be updated today, Thursday, Dec. 24, and through the week with the latest information on COVID-19 in South Florida.
-
More than 350,000 doses of Moderna’s COVID-19 vaccine arrive in Florida this week, as the state’s vaccination campaign ramps up in force. So far, the FDA has authorized two COVID-19
-
This post will be updated today, Monday, Dec. 21, and through the week with the latest information on COVID-19 in South Florida.
-
Florida continues to see increasing infections and deaths as the second COVID-19 vaccine heads to the state.
-
Despite being founded a decade ago, Moderna has never had a product make it to market. And the company registered its first factory with the Food and Drug Administration just this week.
-
Advisers to the Food and Drug Administration voted 20-0 to recommend that the agency authorize Moderna's vaccine for emergency use during the pandemic. There was a single abstention.
-
Two days before a panel of experts is set to review Moderna's COVID-19 vaccine and advise the Food and Drug Administration, documents show the vaccine is 94% effective and well-tolerated.